Your choice
of nicotine products

Enorama Pharma AB is a Swedish pharmaceutical company listed on Nasdaq First North Growth Market. We focus on the development and commercialization of consumer friendly, oral nicotine products.

Your choice of nicotine products

Enorama Pharma AB is a Swedish pharmaceutical company listed on Nasdaq First North Growth Market. We focus on development and manufacturing of consumer friendly medicated chewing gums containing well proven generic substances.

Research & Development

Fields of research

Research & Development

Fields of research

Nicotine Chewing Gum for smoking cessation

A unique, patented, consumer-friendly nicotine gum ready for sale.

Nicotine Pouches in 6 flavours and 3 strengths

We develop, manufacture and sell 100 % tobacco-free nicotine pouches under our own brand NIC-S.

ChewMed®

Enorama Pharma develops and manufactures medicated chewing gums. We utilize a modern technology platform, the ChewMed® technology, that is better suited for production of medicated chewing gums than traditional technologies.

Articles

News

NIC-S at WTME in Dubai

November 15, 2024

This week, NIC-S co-exhibited with DS Group at the World Tobacco Middle East, held at [...]

News

NIC-S® wins 2024 Best New Products Award

November 4, 2024

Enorama Pharma is proud to announce that NIC-S has been honored with the distinguished 2024 [...]

News

CS News highlights NIC-S

July 18, 2024

US industry-leading publication, Convenience Store News, presents our nicotine pouches NIC-S, effectively highlighting their unique [...]

News

NIC-S in US stores

July 15, 2024

Our nicotine pouch NIC-S is now available in more than 700 stores across 21 states. [...]

News

NIC-S now available online in the US

June 18, 2024

We’re thrilled to announce that NIC-S, our premium nicotine pouch, is now available for purchase [...]

News

Awareness of NIC-S on the rise

May 15, 2024

NIC-S is presented and advertised in the latest newsletter from CStore, the primary source for [...]

News

European Patent Office approves Enorama’s patent

May 3, 2024

The European Patent Office (EPO) has now granted Enorama’s patent for a nicotine-containing chewing gum [...]

News

Enorama has moved back to Malmö city center

March 27, 2024

After 3 years in the neighbourhood of “Västra Hamnen”, we have relocated back to the [...]

Press

Kvartalsrapport - Enorama Pharma AB (publ)

20-11-2024

1 januari – 30 september 2024 jämfört med 1 januari – 30 september 2023 · Nettoomsättningen uppgick till 13 127 (1 186) KSEK · Rörelseresultatet uppgick till - 20 842 (-30 960) KSEK · Resultat före skatt uppgick till -21 800 (-30 865) KSEK · Resultat per aktie* uppgick till -0,36 (-0,83) SEK · Soliditeten uppgick…

Stock market